Vabysmo 6 mg (0.05 mL of 120 mg/mL solution) intravitreal injection Images

Generic Name: faricimab

This medication has been identified as Vabysmo 6 mg (0.05 mL of 120 mg/mL solution) intravitreal injection. It is supplied by Genentech, Inc.

Vabysmo is used in the treatment of Macular Edema Following Retinal Vein Occlusion; Macular Edema; Macular Degeneration; Diabetic Macular Edema and belongs to the drug class anti-angiogenic ophthalmic agents. Vabysmo 6 mg (0.05 mL of 120 mg/mL solution) intravitreal injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Vabysmo

Generic Name

faricimab

Strength

6 mg (0.05 mL of 120 mg/mL solution) intravitreal injection

Availability

Prescription only

Drug Class

Anti-angiogenic ophthalmic agents

CSA Schedule

Not a controlled drug

Labeler / Supplier

Genentech, Inc.

National Drug Code (NDC)

50242-0096

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer